Natus Medical Deferred Revenue Trend

Natus Medical Incorporated -- USA Stock  

USD 30.55  0.30  0.97%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Deferred Revenue of Natus Medical Incorporated with missing and latest data points interpolated. A component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue, including sales, license fees, and royalties, but excluding interest income.
Deferred Revenue  10 Years Trend  
Increasing
Slightly volatile
 Deferred Revenue 
      Timeline 

Natus Medical Deferred Revenue Over Time

2016-12-31  23,346,000 
2017-12-31  23,346,000 
2018-12-31  18,240,526 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  10,766,810
Geometric Mean  7,426,955
Coefficient Of Variation  69.09
Mean Deviation  5,980,286
Median  11,311,000
Standard Deviation  7,439,023
Range  23,034,000
R Value  0.92
R Squared  0.84
Significance  0.00001095
Slope  1,749,754

Currently Trending

V   
 NYQ 
Sold over 20 shares of
few hours ago ago
Traded for 121.85
S   
 NYQ 
Purchased over 500 shares of
few hours ago ago
Traded for 5.39
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 10.61